Universitetssykehuset Nord-Norge HF

Tromsø N-9038

3 studies enrolling now · 7 studies all time

What they study most

Colitis, Ulcerative, Crohn's Disease, Inflammatory Bowel Diseases, Malignant Melanoma, Metabolic Dysfunction-Associated Steatotic Liver Disease, Ulcerative Colitis, Ulcerative Colitis Chronic

Studies at this site

• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) — Recruiting now
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma — Completed